Calcul Increase In Capital

Corporate Finance Tool

Calcul Increase in Capital Calculator

Estimate nominal capital increase, share premium, net proceeds, dilution, and post-transaction ownership metrics for a share issue, rights offering, or equity financing round.

Capital Increase Calculator

Enter the current capital structure and the terms of the new share issue. The calculator will estimate how the operation affects share capital, premium, proceeds, and dilution.

Registered share capital before the transaction.
Total number of shares currently issued.
Number of additional shares created in the capital increase.
Amount credited to share capital per new share.
Subscription price paid by new or existing investors.
Legal, banking, listing, and advisory costs.
Optional, used to estimate theoretical ex-rights pricing.
Used only for formatting the result output.
The core math is the same, but explanatory notes adapt to the selected method.

Results

Enter your figures and click the calculate button to view the capital increase breakdown.

Capital Structure Visualization

The chart compares existing share capital, nominal increase, share premium, and issue costs so you can see how the financing round is composed.

Expert Guide to Calcul Increase in Capital

A calcul increase in capital is the process of measuring how a company’s equity base changes when it issues new shares. In practical terms, this means determining the amount added to legal share capital, identifying any share premium created above nominal value, estimating the total funds raised, and assessing the ownership impact on current shareholders. Whether you are a founder, CFO, minority investor, analyst, accountant, or corporate lawyer, understanding this calculation is essential because a capital increase affects governance, balance sheet strength, financing flexibility, and valuation expectations.

The phrase “increase in capital” is used across many jurisdictions to describe an equity financing operation in which a company creates and issues additional shares. The transaction may be a public offering, a private placement, a rights issue offered to existing shareholders, an employee share plan, or a conversion event tied to debt or preferred securities. Even when legal documentation differs from one country to another, the arithmetic is built on the same core pillars: number of shares issued, nominal value per share, issue price per share, and associated transaction costs.

At the heart of the calculation is a simple distinction. The nominal increase is the amount added to registered share capital. The share premium is the excess of the issue price over the nominal value. For example, if a company issues 10,000 new shares with a nominal value of 10 and an issue price of 14, then 100,000 is added to legal share capital and 40,000 becomes share premium. The gross proceeds are 140,000. If issuance fees total 8,000, the net funds entering the business are 132,000.

The basic formula set

  • Nominal capital increase = New shares × Nominal value per share
  • Gross proceeds = New shares × Issue price per share
  • Share premium = New shares × (Issue price − Nominal value)
  • Net proceeds = Gross proceeds − Issue costs
  • New total share capital = Current share capital + Nominal capital increase
  • Total shares after issue = Current shares + New shares
  • Dilution for non-participating existing holders = New shares ÷ Total shares after issue

These formulas answer most first-level questions. They tell management how much permanent equity is being added, help investors estimate ownership reduction if they do not subscribe, and allow accountants to record the split between legal capital and premium reserves. If the deal is structured as a rights issue and the market price is known, another metric becomes useful: the theoretical ex-rights price, often called TERP. This is a weighted average price based on the old market price and the new subscription price.

Why capital increase calculations matter

A company does not raise equity only to “get cash.” It raises equity because capital structure matters. More equity can improve leverage ratios, support regulatory capital requirements, fund an acquisition, strengthen a startup runway, finance expansion, or restore solvency after losses. A correct calculation helps management answer several strategic questions:

  1. How much capital is legally being added to share capital versus premium reserves?
  2. How much cash will actually be available after underwriting, legal, and filing fees?
  3. How much dilution will current investors suffer if they do not participate?
  4. How should the financing be priced relative to prevailing market conditions?
  5. Will the transaction improve the company’s balance sheet enough to justify the discount offered to new investors?

This is why a robust calcul increase in capital should never stop at one output. The best analysis presents legal capital change, gross cash raised, net proceeds, total shares after issue, dilution percentage, and where appropriate, rights issue pricing metrics.

Understanding dilution in practical terms

Dilution is one of the most misunderstood parts of a capital increase. Many shareholders focus only on the lower percentage ownership after new shares are created. That is important, but it is not the whole story. Dilution affects voting rights, dividend entitlement per share, and future earnings per share. However, if the capital increase funds projects with attractive returns or strengthens a weak balance sheet, the economic effect can still be positive. In other words, ownership percentage falls, but enterprise value may rise enough to offset the loss.

Assume a company has 50,000 shares outstanding and issues 10,000 more. The post-transaction share count becomes 60,000. A shareholder who owned 5,000 shares previously held 10% of the business. If that shareholder does not participate in the issue, they now own 5,000 out of 60,000, or 8.33%. The ownership dilution is therefore 1.67 percentage points, and the issue itself represents 16.67% of the new total shares. Rights offerings are designed to reduce this problem by giving current shareholders a chance to subscribe in proportion to their existing holdings.

Rights issue logic and TERP

In a rights issue, existing investors receive rights to buy new shares, usually at a discount to the current market price. This protects pre-emptive rights and gives shareholders a path to maintain their proportional ownership. The TERP formula estimates the theoretical market price after the rights detach:

  • TERP = ((Current shares × Current market price) + (New shares × Issue price)) ÷ Total shares after issue

If a company has 50,000 shares trading at 18 and issues 10,000 new shares at 14, the theoretical ex-rights price is:

((50,000 × 18) + (10,000 × 14)) ÷ 60,000 = 17.33 approximately.

This means the post-rights price should theoretically settle below the old market price because discounted shares were introduced. That does not automatically imply value destruction. It reflects the mechanics of averaging old and new equity. Existing holders who receive rights are compensated by the value of those rights.

How accountants and lawyers look at the same transaction

Finance teams typically focus on proceeds, dilution, and valuation impact. Accountants focus on the split between share capital and premium, plus treatment of direct issue costs. Corporate lawyers focus on authorization limits, board and shareholder approvals, prospectus requirements, pre-emption rights, and filing formalities. A strong capital increase model therefore serves multiple audiences. It should make legal capital movements transparent while still helping commercial decision-makers understand the economics.

In many legal systems, issue expenses reduce the premium reserve or are offset against equity rather than being recognized as a standard operating expense. That is one reason the distinction between gross and net proceeds matters. Gross proceeds tell you what investors paid. Net proceeds show what equity financing really delivered to the business after the transaction was executed.

Real-world market context that influences capital increase decisions

The best moment to raise equity often depends on capital market conditions. When interest rates are high, debt financing becomes more expensive, and management teams may turn to equity despite dilution. When equity markets are strong, companies can often price a share issue more favorably and reduce the discount required to attract investors. The statistics below show why financing conditions cannot be separated from capital increase strategy.

Table 1: U.S. effective federal funds rate annual averages

Year Average Effective Federal Funds Rate Interpretation for Equity Financing
2021 0.08% Debt was unusually cheap, reducing pressure for dilutive equity financing.
2022 1.68% Rapid tightening began to lift the cost of borrowing and refinancing.
2023 5.02% High short-term rates made equity comparatively more attractive for some issuers.

These annual averages are based on Federal Reserve Economic Data published by the Federal Reserve Bank of St. Louis. In a high-rate environment, a company may accept moderate dilution to avoid covenant-heavy or costly debt.

Table 2: Long-run U.S. annualized returns by major asset class

Asset Class Approximate Long-Run Annualized Return Why It Matters for Capital Increase Pricing
U.S. equities About 9.8% Investors generally demand meaningful upside when subscribing to new equity.
Long-term U.S. government bonds About 4.6% Provides a lower-risk benchmark against which equity risk is priced.
U.S. Treasury bills About 3.3% Represents the short-duration cash alternative for investors.

These historical return figures are commonly referenced from long-run market datasets used in academic and valuation work, such as the NYU Stern data series. For a company planning a capital increase, these benchmarks help explain why investors may require a discount or a premium growth story before committing new funds.

Step-by-step method for a reliable calcul increase in capital

  1. Identify the current base. Record current share capital and current shares outstanding. These must be internally consistent.
  2. Define the new issue. Determine how many new shares will be issued and what nominal value attaches to each share.
  3. Set the price. Decide the issue price. This may be negotiated privately or set with reference to a market discount in a listed transaction.
  4. Estimate direct costs. Include legal fees, placement commissions, listing costs, documentation, and advisory expenses.
  5. Calculate nominal increase and premium. Split the proceeds correctly between legal capital and premium reserve.
  6. Compute post-issue shares and dilution. Assess ownership changes for investors who do not participate.
  7. Add TERP if relevant. For listed companies, compare current market price with the issue price and estimate theoretical ex-rights value.
  8. Interpret the result strategically. Ask whether the capital increase improves solvency, extends runway, funds growth, or merely patches a weak balance sheet.

Common mistakes to avoid

  • Confusing issue price with nominal value. The full issue price is not always added to legal capital.
  • Ignoring issue costs. Gross proceeds can materially overstate the funds actually available to management.
  • Using dilution without context. A dilutive issue can still create value if proceeds are invested well.
  • Overlooking pre-emptive rights. Existing shareholders may be entitled to subscribe first, changing both allocation and control outcomes.
  • Skipping post-money logic. Total shares after the issue matter for valuation per share, voting rights, and earnings metrics.

How startups, SMEs, and listed companies use the calculation differently

Startups often frame the capital increase around runway, post-money valuation, option pool effects, and protective provisions. Small and medium-sized companies usually focus on balance sheet resilience, bankability, and family or founder control. Listed companies focus more heavily on rights issue discounts, TERP, institutional demand, underwriting, and signaling effects. The arithmetic is identical, but the interpretation changes. In early-stage finance, dilution may be accepted because survival and growth are the priority. In public markets, pricing discipline and market communication become central.

Authoritative resources for deeper due diligence

If you are evaluating a real transaction, pair this calculator with primary-source guidance from regulators, investor education portals, and university-level market data references. The following sources are especially useful:

Final interpretation framework

When you complete a calcul increase in capital, do not stop at the spreadsheet output. Ask four final questions. First, is the company raising enough capital to achieve a specific objective? Second, is the issue priced fairly relative to risk, market conditions, and the rights of existing shareholders? Third, what happens to control and voting power after the issue? Fourth, how much of the transaction value is consumed by direct fees and discounts? If you can answer those four questions with confidence, you are using the calculation the way senior finance professionals do.

In summary, a proper increase in capital analysis combines legal mechanics, valuation logic, and investor impact. The nominal increase tells you what happens to share capital. The premium tells you how much is contributed above par. Net proceeds tell you what the company actually receives. Dilution tells you who gains or loses ownership share. TERP helps listed companies understand post-offer pricing mechanics. Used together, these metrics create a complete picture of the transaction.

This calculator and guide are educational tools and do not replace legal, tax, accounting, or securities law advice. Capital increase procedures vary by jurisdiction, corporate charter, exchange rules, and investor agreements.

Leave a Comment

Your email address will not be published. Required fields are marked *

Scroll to Top